For years, Medtronic has trailed behind Dexcom and Abbott in the continuous glucose monitor market. Its newest entry in the space, however, may give its competitors a run for their money. The ...
Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...
DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with ...
The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system. The all-in-one sensor is said to eliminate the ...
Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous glucose monitor, following a similar approval for the pairing in Europe early ...
In another boost to its diabetes portfolio, Medtronic plc was granted CE mark approval for its Simplera continuous glucose monitor (CGM) sensor. The EU greenlight for Simplera follows the U.S. FDA ...
Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology ...
Medtronic’s (NYSE:MDT) Simplera continuous glucose monitor (CGM) has received regulatory approval from the U.S. Food and Drug Administration (FDA). Simplera is the company's first disposable, ...
With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results